Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula (Q37995041)

26 August 2017

0 references

Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula (English)

1 reference

26 August 2017

0 references

1 reference

S L Gans

1 reference

26 August 2017

H L van Westreenen

1 reference

26 August 2017

J J S Kiewiet

1 reference

26 August 2017

E A J Rauws

1 reference

26 August 2017

D J Gouma

1 reference

26 August 2017

M A Boermeester

1 reference

26 August 2017

language of work or name

English

0 references

publication date

20 March 2012

1 reference

British Journal of Surgery

26 August 2017

published in

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

754-760

1 reference

Postoperative pancreatic fistula: an international study group (ISGPF) definition.

26 August 2017

cites work

1 reference

Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials

21 January 2018

1 reference

Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection

21 January 2018

1 reference

Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas

21 January 2018

1 reference

Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae

21 January 2018

1 reference

Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution

21 January 2018

1 reference

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

Octreotide and gastrointestinal fistulae

21 January 2018

1 reference

Somatostatin in the management of gastrointestinal fistulas. A multicenter trial.

21 January 2018

1 reference

Endoscopic transpapillary stenting or conservative treatment for pancreatic fistulas in necrotizing pancreatitis: multicenter series and literature review

21 January 2018

1 reference

Endoscopic treatment of pancreatic fistulas.

21 January 2018

1 reference

Endoscopic treatment of postsurgical external pancreatic fistulas.

21 January 2018

1 reference

Transpapillary stenting for pancreaticocutaneous fistulas

21 January 2018

1 reference

Pancreatic stent placement for duct disruption.

21 January 2018

1 reference

Predictors of outcome in pancreatic duct disruption managed by endoscopic transpapillary stent placement

21 January 2018

1 reference

Incidence, risk factors, and prevention of post-ERCP pancreatitis

21 January 2018

1 reference

Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study

21 January 2018

1 reference

21 January 2018

1 reference

Pancreatic Fistula Rate after Pancreatic Resection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BJS.8709

1 reference

26 August 2017

1 reference